Latest News

Date Title Topic
05 Oct 2016 ESMO 2016 Press Release: Reporting of Adverse Events in Targeted Therapy and Immunotherapy Trials is “Suboptimal” Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
04 Oct 2016 ESMO 2016 Press Release: Impact of Cognitive Functions on Oral Cancer Therapies
30 Sep 2016 Press Release: New Edition of ESMO/ASCO Global Curriculum in Medical Oncology – Setting Standards for Modern Training
29 Sep 2016 ESMO 2016 Press Release: Ki67 May Help Avoid Sentinel Lymph Node Biopsy in Some Patients Breast cancer - Basic science
29 Sep 2016 FDA Modifies the Dosage Regimen for Currently Approved Indications for Nivolumab Genitourinary cancers - Melanoma and other skin tumours - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
28 Sep 2016 Media Alert: ESMO 2016 Poster Abstracts Published Online Today
28 Sep 2016 EU-US collaboration to boost medicine development for rare diseases Bioethics, legal and economic issues
27 Sep 2016 NICE Releases a Quality Standard in Skin Cancer Melanoma and other skin tumours
23 Sep 2016 Press Release: Precision Medicine Trial First of its Kind to Show Benefit to Patients
Press Conference Programme
22 Sep 2016 EMA Recommends Granting a Marketing Authorisation for Edotreotide Imaging - Endocrine and neuroendocrine tumours
eUpdate – Treatment Algorithms
21 Sep 2016 EMA Recommends Granting a Conditional Marketing Authorisation for Ixazomib Haematologic malignancies - Anticancer agents & Biologic therapy
eUpdate – Treatment Recommendations
eUpdate – Treatment Recommendations